Search Results 261-270 of 16501 for Proliferation
No proliferative benign lesions (e.g. fibroadenomas) identified; Heterogeneously dense or extremely dense parenchyma (BIRADs density category 3 or 4); MBI ...
Proliferative glomerulonephritis (PGN); HELLP syndrome. Patients who have atypical features for the above diseases or have abnormalities in the initial tests ...
Bone marrow (including pancytopenia without any detectable B-cell proliferation);; Liver (coagulopathy, transaminitis and/or hyperbilirubinemia);; Lungs ...
As part of this aim we will establish the proliferation status of the tumor cells. We will in parallel examine CTC to determine the correlation between BDTC ...
With disordered proliferative endometrium (DPEM) as the referent, AH significantly increased carcinoma risk (RR=14, 95% CI, 5-38). Risk was highest 1-5 ...
Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine ...
... proliferation and survival. The compound causes G1 cell cycle arrest and is anti-proliferative across a broad range of haematological cell models ...
Molecular and epigenetic mechanisms of stem and progenitor cell proliferation and differentiation, as well as tissue degeneration and regeneration; Immune ...
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. JCI Insight. 2017 Jan 26; 2(2): ...
... proliferation with pleomorphic, mature megakaryocytes (differences in size). Presence of JAK2V617F or JAK2 exon 12 mutation. Serum erythropoietin level ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.